Quest Diagnostics Incorporated Stock Buy Hold or Sell Recommendation
| DGX Stock | USD 130.09 1.65 1.28% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Quest Diagnostics Incorporated is 'Hold'. Macroaxis provides Quest Diagnostics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding DGX positions. The advice algorithm takes into account all of Quest Diagnostics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Quest Diagnostics' buy or sell advice are summarized below:
Real Value 136.5 | Target Price 146.31 | Hype Value 129.97 | Market Value 130.09 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Quest Diagnostics Incorporated given historical horizon and risk tolerance towards Quest Diagnostics. When Macroaxis issues a 'buy' or 'sell' recommendation for Quest Diagnostics Incorporated, the advice is generated through an automated system that utilizes algorithms and statistical models.
Quest |
Execute Quest Diagnostics Buy or Sell Advice
The Quest recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Quest Diagnostics Incorporated. Macroaxis does not own or have any residual interests in Quest Diagnostics Incorporated or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Quest Diagnostics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Quest Diagnostics Trading Alerts and Improvement Suggestions
| Quest Diagnostics has a strong financial position based on the latest SEC filings | |
| Over 92.0% of the company shares are held by institutions such as insurance companies | |
| On 22nd of April 2024 Quest Diagnostics paid $ 0.75 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Earnings Preview Quest Diagnostics Q1 Earnings Expected to Decline |
Quest Diagnostics Returns Distribution Density
The distribution of Quest Diagnostics' historical returns is an attempt to chart the uncertainty of Quest Diagnostics' future price movements. The chart of the probability distribution of Quest Diagnostics daily returns describes the distribution of returns around its average expected value. We use Quest Diagnostics Incorporated price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Quest Diagnostics returns is essential to provide solid investment advice for Quest Diagnostics.
| Mean Return | -0.05 | Value At Risk | -1.66 | Potential Upside | 2.01 | Standard Deviation | 1.13 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Quest Diagnostics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Quest Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Quest Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Quest Diagnostics Incorporated backward and forwards among themselves. Quest Diagnostics' institutional investor refers to the entity that pools money to purchase Quest Diagnostics' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.9 M | Amvescap Plc. | 2023-12-31 | 1.7 M | Grantham, Mayo, Van Otterloo & Co., Llc | 2023-12-31 | 1.7 M | Wells Fargo & Co | 2023-12-31 | 1.5 M | Fmr Inc | 2023-12-31 | 1.3 M | Northern Trust Corp | 2023-12-31 | 1.1 M | Bank Of America Corp | 2023-12-31 | 1 M | Legal & General Group Plc | 2023-12-31 | 1 M | Ameriprise Financial Inc | 2023-12-31 | 1 M | Vanguard Group Inc | 2023-12-31 | 13.6 M | Blackrock Inc | 2023-12-31 | 10.6 M |
Quest Diagnostics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 1.1B | (34M) | (286M) | (557M) | 371M | 389.6M | |
| Free Cash Flow | 843M | 1.6B | 1.8B | 1.3B | 864M | 719.7M | |
| Depreciation | 329M | 361M | 408M | 437M | 439M | 264.3M | |
| Other Non Cash Items | (98M) | (59M) | (364M) | 69M | 100M | 151.5M | |
| Dividends Paid | 286M | 297M | 309M | 305M | 314M | 329.7M | |
| Capital Expenditures | 400M | 418M | 403M | 404M | 408M | 289.1M | |
| Net Income | 906M | 1.5B | 2.1B | 1.0B | 850M | 646.8M | |
| End Period Cash Flow | 1.2B | 1.2B | 872M | 315M | 686M | 720.3M | |
| Change To Netincome | (27M) | 123M | (257M) | 147M | 169.1M | 164.9M | |
| Change To Inventory | 16M | 4M | 29M | (20M) | (23M) | (21.9M) | |
| Net Borrowings | 124M | 832M | (805M) | (2M) | (1.8M) | (1.7M) | |
| Investments | (411M) | (772M) | 752M | (543M) | (1.1B) | (1.1B) | |
| Change Receivables | (63M) | (455M) | 81M | 246M | 282.9M | 297.0M |
Quest Diagnostics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Quest Diagnostics or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Quest Diagnostics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Quest stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.06 | |
β | Beta against NYSE Composite | -0.06 | |
σ | Overall volatility | 1.12 | |
Ir | Information ratio | -0.12 |
Quest Diagnostics Volatility Alert
Quest Diagnostics Incorporated exhibits very low volatility with skewness of 0.59 and kurtosis of -0.4. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Quest Diagnostics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Quest Diagnostics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Quest Diagnostics Fundamentals Vs Peers
Comparing Quest Diagnostics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Quest Diagnostics' direct or indirect competition across all of the common fundamentals between Quest Diagnostics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Quest Diagnostics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Quest Diagnostics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Quest Diagnostics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Quest Diagnostics to competition |
| Fundamentals | Quest Diagnostics | Peer Average |
| Return On Equity | 0.15 | -0.31 |
| Return On Asset | 0.0621 | -0.14 |
| Profit Margin | 0.09 % | (1.27) % |
| Operating Margin | 0.13 % | (5.51) % |
| Current Valuation | 19.14 B | 16.62 B |
| Shares Outstanding | 111.06 M | 571.82 M |
| Shares Owned By Insiders | 0.43 % | 10.09 % |
| Shares Owned By Institutions | 91.79 % | 39.21 % |
| Number Of Shares Shorted | 2.55 M | 4.71 M |
| Price To Earning | 14.57 X | 28.72 X |
| Price To Book | 2.26 X | 9.51 X |
| Price To Sales | 1.54 X | 11.42 X |
| Revenue | 9.25 B | 9.43 B |
| Gross Profit | 3.47 B | 27.38 B |
| EBITDA | 1.26 B | 3.9 B |
| Net Income | 850 M | 570.98 M |
| Cash And Equivalents | 315 M | 2.7 B |
| Cash Per Share | 6.15 X | 5.01 X |
| Total Debt | 5.37 B | 5.32 B |
| Debt To Equity | 0.73 % | 48.70 % |
| Current Ratio | 1.46 X | 2.16 X |
| Book Value Per Share | 56.82 X | 1.93 K |
| Cash Flow From Operations | 1.27 B | 971.22 M |
| Short Ratio | 2.81 X | 4.00 X |
| Earnings Per Share | 7.49 X | 3.12 X |
| Price To Earnings To Growth | 1.52 X | 4.89 X |
| Target Price | 142.29 | |
| Number Of Employees | 40 K | 18.84 K |
| Beta | 0.89 | -0.15 |
| Market Capitalization | 14.26 B | 19.03 B |
| Total Asset | 14.02 B | 29.47 B |
| Retained Earnings | 8.82 B | 9.33 B |
| Working Capital | 557 M | 1.48 B |
Note: Sale by John Ziegler of 1953 shares of Quest Diagnostics [view details]
Quest Diagnostics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Quest . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 36543.0 | |||
| Daily Balance Of Power | 0.583 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 129.8 | |||
| Day Typical Price | 129.89 | |||
| Price Action Indicator | 1.12 | |||
| Period Momentum Indicator | 1.65 |
About Quest Diagnostics Buy or Sell Advice
When is the right time to buy or sell Quest Diagnostics Incorporated? Buying financial instruments such as Quest Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 4.7B | 4.6B | 5.4B | 3.1B | Total Assets | 13.6B | 12.8B | 14.0B | 8.5B |
Use Investing Ideas to Build Portfolios
In addition to having Quest Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Restaraunts Hotels Motels Thematic Idea Now
Restaraunts Hotels Motels
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Restaraunts Hotels Motels theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Restaraunts Hotels Motels Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Quest Diagnostics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Quest Diagnostics information on this page should be used as a complementary analysis to other Quest Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Quest Stock analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |
Is Quest Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quest Diagnostics. If investors know Quest will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quest Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.868 | Dividend Share 2.84 | Earnings Share 7.49 | Revenue Per Share 82.607 | Quarterly Revenue Growth (0.02) |
The market value of Quest Diagnostics is measured differently than its book value, which is the value of Quest that is recorded on the company's balance sheet. Investors also form their own opinion of Quest Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Quest Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quest Diagnostics' market value can be influenced by many factors that don't directly affect Quest Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quest Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quest Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quest Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.